Cover Image

自我調節止痛法 (PCA) 市場:2015年

Patient Controlled Analgesia

出版商 Greystone Research Associates 商品編碼 332544
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
自我調節止痛法 (PCA) 市場:2015年 Patient Controlled Analgesia
出版日期: 2015年06月11日 內容資訊: 英文


本報告提供自我調節止痛法 (PCA) 市場相關調查、疼痛管理市場趨勢與PCA設備的概要與適應、市場資料與預測、參與企業簡介彙整。



  • PCA的成長
  • 需求促進要素
  • 人口統計的變遷
  • 變化的疼痛管理指南
  • 自我施打的增加
  • 技術市場的推動因素
  • PCA市場策略
  • PCA設計因素
  • 患者的可用性
  • 醫療錯誤和安全性
  • 用量和鎖定間隔時間


  • 輸液幫浦
  • 住院/床邊輸液設備
  • 門診病人用設備
  • 開發階段的PCA設備
  • 經鼻噴霧
  • 舌下噴霧
  • 肺吸入器



  • 住院
  • 門診病人
  • 居家醫療


  • 外傷
  • 術後/產後痛
  • 癌症疼痛
  • 慢性疼痛
  • 傷害性疼痛
  • 神經性疼痛


  • 醫療法律規章
  • 業界標準
  • 護理管理措施
  • 看護者培訓和病患監測


  • 北美
  • 歐洲
  • 日本
  • 其他地區


Product Code: PCA477R

An increasing understanding of the physiology of pain coupled with patient-friendly dosage forms and delivery techniques is providing caregivers and prescribers with improved tools for helping patient manage their own pain. New and emerging pain delivery products that allow patients to play an active role in the timing and dosing of their pain medication allow patients to balance pain relief and medication side effects, and potentially improve quality-of-life. Pain management philosophy is based on the premise of treating pain early and aggressively. This is based on research that pain is tightly correlated with decreased quality of life, and increased incidence of anxiety and depression. Further, pain causes the physiologic release of destructive enzymes that can damage even healthy tissue. The aging population - particularly in North America and Western Europe, where the quality of medical care is high and consumers enjoy a relatively high standard of living - will create a growing market of mature and elderly needing drug therapies and pain management for a variety of maladies associated with the aging process. These factors are attracting well-financed players and elevating alliance activity in this sector.


  • Analyzes and evaluates patient controlled analgesia (PCA) products and assesses the market potential for existing and probable future products
  • Analyzes product designs, technologies and market development issues
  • Provides detailed descriptions of PCA market segments, market demographics, and business strategies
  • Provides market data and forecasts to 2022
  • Profiles PCA product companies, their product development activities, business strategies, and corporate alliances and affiliations
  • Assesses the importance of pharma-device alliances and design partnerships
  • Evaluates the impact of economic, technology, and regulatory factors on PCA markets

Table of Contents

Summary of Contents

  • Executive Summary
  • Pain Management Market Dynamics
  • Tracking the Growth of PCA
  • Demand Drivers
  • Demographic Shifts
  • Evolving Pain Management Guidelines
  • Growth in Self-Administration
  • Technology Market Drivers
  • PCA Market Strategies
  • PCA Design Factors
  • Patient Usability
  • Medication Errors and Safety
  • Dose and Lockout Intervals
  • Bolus Dosing
  • PCA Device Assessments
  • Infusion Pumps
  • In-Patient/Bedside PCA Infusion
  • Ambulatory PCA Infusion
  • Active Transdermal Systems
  • Development-Stage PCA Devices
  • Intranasal Sprays
  • Sublingual Sprays
  • Pulmonary (Systemic) Inhalers
  • PCA Market Assessments and Analysis
  • PCA Market Segments
  • In-Patient
  • Ambulatory
  • Home Care
  • PCA Indications
  • Trauma
  • Post-Operative/Obstetric Pain
  • Cancer Pain
  • Chronic Pain
  • Nociceptive Pain
  • Neuropathic Pain
  • Market Factors
  • Healthcare Regulations
  • Industry Standards
  • Managed Care Initiatives
  • Caregiver Training & Patient Monitoring
  • Market Data & Forecasts
  • North America
  • Europe
  • Japan
  • Other Geographies
  • Sector Participant Company Profiles
Back to Top